Peimine, a bioactive substance isolated from Chinese medicine Fritillaria, can potentially suppress
pulmonary fibrosis (PF); however, its therapeutic mechanism remains unclear. Recent evidence suggests the participation of M2-type macrophages in the pathogenesis of PF. The present study aimed to investigate the effect of
peimine on a
bleomycin (BLM)-induced PF rat model and the underlying mechanism of this effect. After BLM administration,
peimine was administered to rats from day 29 to day 42, with
pirfenidone (PFD) as a positive control. H&E and Masson's
trichrome stain were used to analyze histological changes. Q-PCR and western blotting were used to measure
mRNA levels and
protein levels, respectively. High-throughput
RNA sequencing (
RNA-seq) technology detected the differentially expressed genes (DEGs) regulated by
peimine. Our results revealed that
peimine treatment significantly ameliorated BLM-induced PF by suppressing histological changes and
collagen deposition. In addition,
peimine decreased the number of M2 macrophages and the expression of profibrotic factors.
RNA-seq results showed that DEGs regulated by
peimine in IL-4-induced macrophages were mainly associated with immune system processes, the PI3K/Akt pathway, and the MAPKs pathway. Then, immunofluorescence assay and western blot results demonstrated that
peimine treatment suppressed the expression of p-p38 MAPK and p-Akt (s473) and also inhibited the nuclear translocation of p-STAT6. In conclusion, the present study demonstrated that
peimine has a protective effect on PF through the suppression of M2 polarization of macrophages by inhibiting the STAT6,
p38 MAPK, and Akt signals.